Xu Yuan

CIK 00018582143 companiesSAN DIEGO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001858214

Recent Transactions

29 trades

Award
FATE THERAPEUTICS INC$FATE
Stock Option (Right to Buy)
2026-06-12+87,900→ 87,900 total
Award
Xilio Therapeutics, Inc.$XLO
Stock Option (right to buy)
2026-06-11+5,000→ 5,000 total
Disposition to Issuer
Akero Therapeutics, Inc.
Stock Option (Right to Buy)
2025-12-09−13,000→ 0 total
Disposition to Issuer
Akero Therapeutics, Inc.
Stock Option (Right to Buy)
2025-12-09−15,000→ 0 total
Disposition to Issuer
Akero Therapeutics, Inc.
Stock Option (Right to Buy)
2025-12-09−26,000→ 0 total
Disposition to Issuer
Akero Therapeutics, Inc.
Common Stock
2025-12-09−9,398→ 0 total
Disposition to Issuer
Akero Therapeutics, Inc.
Stock Option (Right to Buy)
2025-12-09−15,000→ 0 total
Disposition to Issuer
Akero Therapeutics, Inc.
Stock Option (Right to Buy)
2025-12-09−26,000→ 0 total
Award
Xilio Therapeutics, Inc.$XLO
Stock Option (right to buy)
2025-06-11+31,000→ 31,000 total
Award
Akero Therapeutics, Inc.
Common Stock
2025-06-03+9,398→ 9,398 total
Award
FATE THERAPEUTICS INC$FATE
Stock Option (Right to Buy)
2025-05-29+55,000→ 55,000 total
Sale
FATE THERAPEUTICS INC$FATE
Common Stock
2024-08-06$4.23/sh−633→ 8,669 total
Award
Xilio Therapeutics, Inc.$XLO
Stock Option (right to buy)
2024-06-14+25,000→ 25,000 total
Award
Akero Therapeutics, Inc.
Stock Option (Right to Buy)
2024-06-08+26,000→ 26,000 total
Award
FATE THERAPEUTICS INC$FATE
Stock Option (Right to Buy)
2024-06-07+40,000→ 40,000 total
Sale
FATE THERAPEUTICS INC$FATE
Common Stock
2023-08-04$3.71/sh−632→ 9,302 total
Award
Akero Therapeutics, Inc.
Stock Option (Right to Buy)
2023-06-23+15,000→ 15,000 total
Sale
FATE THERAPEUTICS INC$FATE
Common Stock
2023-06-14$5.58/sh−3,460→ 9,934 total
Award
Xilio Therapeutics, Inc.$XLO
Stock Option (right to buy)
2023-06-12+13,200→ 13,200 total
Award
FATE THERAPEUTICS INC$FATE
Stock Option (Right to Buy)
2023-06-06+40,000→ 40,000 total
Award
Xilio Therapeutics, Inc.$XLO
Stock Option (right to buy)
2022-06-15+13,200→ 13,200 total
Award
FATE THERAPEUTICS INC$FATE
Common Stock
2022-06-09+8,650→ 13,394 total
Award
FATE THERAPEUTICS INC$FATE
Stock Option (Right to Buy)
2022-06-09+11,893→ 11,893 total
Award
Akero Therapeutics, Inc.
Stock Option (Right to Buy)
2022-06-02+15,000→ 15,000 total
Award
Xilio Therapeutics, Inc.$XLO
Stock Option (right to buy)
2022-01-04+26,400→ 26,400 total
Award
FATE THERAPEUTICS INC$FATE
Common Stock
2021-08-03+4,744→ 4,744 total
Award
FATE THERAPEUTICS INC$FATE
Stock Option (Right to Buy)
2021-08-03+7,501→ 7,501 total
Award
Akero Therapeutics, Inc.
Stock Option (Right to Buy)
2021-06-01+13,000→ 13,000 total
Award
Akero Therapeutics, Inc.
Stock Option (Right to Buy)
2021-04-22−26,000→ 26,000 total

Companies

Recent Filings

Address

C/O FATE THERAPEUTICS, INC. 12278 SCRIPPS SUMMIT DRIVE

SAN DIEGO, CA, 92131

View on SEC.gov